Finally, the results of our study, showing the association of the NT5E gene methylation with poor prognostic factors such as large tumor size, high histologic grade, negative estrogen receptor expression, and negative Bcl-2 expression in breast cancer, support the utility of the NT5E gene methylation as a biomarker of breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.